首页 › 基金 › Bain Capital Life Sciences Investors, LLC › IRON
Bain Capital Life Sciences Investors, LLC 对 IRON 的持仓历史
DISC MEDICINE INC · 医疗保健
Bain Capital Life Sciences Investors, LLC 在 Q3 2026 的 13F 申报中披露持有 IRON(DISC MEDICINE INC)141,234 股,市值约 US$9.2M,约占其申报组合的 0.64%,在其申报持仓中市值排名第 18 位。 Bain Capital Life Sciences Investors, LLC 最近 13 个申报季度中有 11 个季度披露了 IRON 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Bain Capital Life Sciences Investors, LLC 对 IRON 的持仓演变
Bain Capital Life Sciences Investors, LLC 于 Q3 2023 首次披露 IRON 持仓:1,332,545 股(约 US$62.6M)。 该持仓在 Q3 2024 达到峰值 1,795,735 股,市值约 US$88.2M。 在 11 次申报中,Bain Capital Life Sciences Investors, LLC 1 次增持、3 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 141,234 股、市值约 US$9.2M。 持仓曾出现大幅变动:Q2 2024 增持约 36% (随后一个季度股价上涨 9%)、Q4 2024 减持约 45% (随后一个季度股价下跌 22%)、Q2 2025 减持约 41% (随后一个季度股价上涨 25%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.33M | $62.60M | 新进 |
| Q4 2023 | 1.33M | $76.97M | 持有 |
| Q1 2024 | 1.32M | $82.01M | 减持 |
| Q2 2024 | 1.80M | $80.93M | 增持 |
| Q3 2024 | 1.80M | $88.24M | 持有 |
| Q4 2024 | 983.50K | $62.35M | 减持 |
| Q1 2025 | 983.50K | $48.82M | 持有 |
| Q2 2025 | 583.50K | $30.90M | 减持 |
| Q1 2026 | 141.23K | $9.03M | 新进 |
| Q2 2026 | 141.23K | $10.33M | 持有 |
| Q3 2026 | 141.23K | $9.25M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IRON 与 13F 数据
IRON(DISC MEDICINE INC)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 IRON,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Vestal Point Capital, LP (US$113.4M), Frazier Life Sciences Management, L.P. (US$99.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IRON 的基金
- RA CAPITAL MANAGEMENT, L.P. 2.45M 股 · $179.21M · Q2 2026
- Vestal Point Capital, LP 1.55M 股 · $113.37M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.35M 股 · $99.09M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 1.38M 股 · $90.60M · Q3 2026
- TCG Crossover Management, LLC 1.34M 股 · $87.84M · Q3 2026
- BVF INC/IL 1.15M 股 · $84.38M · Q2 2026
- Logos Global Management LP 1.01M 股 · $66.44M · Q3 2026
- Opaleye Management Inc. 855.00K 股 · $62.53M · Q2 2026
- Siren, L.L.C. 888.40K 股 · $58.15M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 657.00K 股 · $48.05M · Q2 2026
- Bellevue Group AG 560.00K 股 · $40.96M · Q2 2026
- Saturn V Capital Management LP 612.66K 股 · $40.10M · Q3 2026
更多关于 Bain Capital Life Sciences Investors, LLC
常见问题
How long has Bain Capital Life Sciences Investors, LLC held IRON?
Bain Capital Life Sciences Investors, LLC has disclosed IRON holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is Bain Capital Life Sciences Investors, LLC's current position in IRON?
As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 141.23K shares of IRON (DISC MEDICINE INC), valued at $9.25M, representing 0.64% of its reported portfolio and ranking #18.
Has Bain Capital Life Sciences Investors, LLC been buying or selling IRON?
In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC held unchanged its position in IRON. The position peaked in Q3 2024 at 1.80M shares.
Which other funds hold IRON?
Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Frazier Life Sciences Management, L.P., among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.